Ketamine therapy, a beacon of hope for treatment-resistant depression, has been gaining traction, but its off-label use has raised concerns about standardization and safety. Imagine a powerful dissociative anesthetic, originally intended for battlefield use, being administered in strip mall clinics without proper monitoring or trained psychiatric support! The risk? A destabilized patient leaving traumatized instead of healed.

Enter the American Society of Ketamine Physicians, Psychotherapists, and Practitioners (ASKP3), armed with a rigorous, interdisciplinary approach using the Delphi method. This isn't your typical boardroom vote; it's an anonymous, iterative process designed to eliminate bias and ego, ensuring that guidelines reflect true expert consensus. With insights from psychiatrists, anesthesiologists, ER physicians, and psychother ...